Alliance for Cancer Gene Therapy

Alliance For Cancer Gene Therapy

Philanthropy, 96 Cummings Point Road, Stamford, , 6902, Connecticut, United States, 1-10 Employees

acgtfoundation.org

  • facebook
  • twitter
  • instagram
  • LinkedIn

phone no Phone Number: +14*********

Who is ALLIANCE FOR CANCER GENE THERAPY

Every year in the U.S., nearly 2 million are diagnosed with cancer. Traditional cancer surgery, chemotherapy and radiation give patients precious moments but no long-term promise. New can...

Read More

map
  • 96 Cummings Point Road, Stamford, Connecticut, 6902, United States Headquarters: 96 Cummings Point Road, Stamford, Connecticut, 6902, United States
  • 2001 Date Founded: 2001
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Philanthropy

SIC SIC Code: 8399 | NAICS Code: 813319 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ALLIANCE FOR CANCER GENE THERAPY

Alliance for Cancer Gene Therapy Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Alliance for Cancer Gene Therapy

Answer: Alliance for Cancer Gene Therapy's headquarters are located at 96 Cummings Point Road, Stamford, , 6902, Connecticut, United States

Answer: Alliance for Cancer Gene Therapy's phone number is +14*********

Answer: Alliance for Cancer Gene Therapy's official website is https://acgtfoundation.org

Answer: Alliance for Cancer Gene Therapy's revenue is $1 Million to $5 Million

Answer: Alliance for Cancer Gene Therapy's SIC: 8399

Answer: Alliance for Cancer Gene Therapy's NAICS: 813319

Answer: Alliance for Cancer Gene Therapy has 1-10 employees

Answer: Alliance for Cancer Gene Therapy is in Philanthropy

Answer: Alliance for Cancer Gene Therapy contact info: Phone number: +14********* Website: https://acgtfoundation.org

Answer: Every year in the U.S., nearly 2 million are diagnosed with cancer. Traditional cancer surgery, chemotherapy and radiation give patients precious moments but no long-term promise. New cancer therapies using the bodys own cells and genes are changing this. In 2001, Alliance for Cancer Gene Therapy became one of the first and only organizations to embrace a progressive vision for the underfunded but exceptionally promising discipline of cancer cell and gene therapy. The organization quickly became a catalytic force in shaping entirely new cancer treatment models by identifying, funding, and advancing the most innovative and impactful translational research in cell and gene therapies. To date, we have awarded more than $30 million in grants to world class cancer researchers representing the top medical institutions in the U.S. and Canada, advancing new approaches to leukemia, lymphoma, ovarian, prostate, sarcoma, glioblastoma, melanoma, lung and pancreatic cancers. Its time for another breakthrough: Today there is an urgent need to translate the profound success of CAR T-cell therapies for blood cancers into successful therapies for the most complex and deadly cancers solid tumor cancers. Current funding priorities work to tackle pancreatic cancer and brain cancer, and to advance the understanding of solid tumor biology that will lead to curative therapies. Help advance our vision for a cure to all cancers. 100% of public donations directly support frontline scientists and programs working on thoroughly vetted and responsibly monitored cancer cell and gene therapy research enabling Alliance for Cancer Gene Therapy to award $30.7 million through 61 grants to 59 innovative researchers, representing 34 top medical institutions in the U.S. and Canada.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access